Results 171 to 180 of about 4,214,592 (290)
RestoreGut <i>- restoration of the gut microbiome after birth by caesarean section: study protocol for a double-blinded, randomised, placebo-controlled trial</i>. [PDF]
Tranæs K +19 more
europepmc +1 more source
Summons of witnesses to Phillip's trial
This document is a legal writ issued by Nicholas Ridgely to the Sheriff of Kent County. The Sheriff was to summon William Barns and his wife, Daniel Needham and his wife, Daniel Nock (Knock) and his wife, Barthia, William Carpenter and his wife, Thomas ...
Kent County Court for the Trial of Negro Slaves
core
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens +6 more
wiley +1 more source
Editorial: Clinical trial design and development in neonatal and perinatal medicine
Mohamed E. Abdel-Latif +11 more
doaj +1 more source
Prediction of late blight severity in a large panel of potato genotypes using low-altitude aerial images and machine learning methods. [PDF]
Loayza H +12 more
europepmc +1 more source
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur +11 more
wiley +1 more source
From Framework to Toolkit: Practical Guidance for Using the PrOcess Evaluation of Trials In Critical care (POETIC) Framework. [PDF]
Emerson LM +4 more
europepmc +1 more source
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington +10 more
wiley +1 more source
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq +8 more
wiley +1 more source
PRE-Pregnancy Weight Loss and the Reducing Effect on CHILDhood Overweight (PREPARE CHILD): clinical trial protocol for a randomised controlled trial. [PDF]
Nygaard M +21 more
europepmc +1 more source

